Literature DB >> 18362573

The assessment of port wine stains in children following multiple pulsed-dye laser treatments.

Sanjay Naran1, John Gilmore, Frederic W-B Deleyiannis.   

Abstract

The purpose of this study was to compare 3 methods of assessment of pediatric port wine stains (PWSs) following multiple pulsed-dye laser (PDL) treatments; (i) parental evaluation, (ii) objective evaluation utilizing L*a*b* color measurement, and (iii) the visual inspection of serial photographs by blinded observers. Twenty-one children who had received at least 4 prior PDL treatments were prospectively enrolled. Following additional PDL treatment, 72.5% of the parental responses indicated a lighter PWS; 85% said that they would continue with further treatment. According to the assessments by 3 observers, only 33.3% to 61.9% (correlation coefficients: 0.41 and 0.54; P < 0.01) of the PDL treatments resulted in a perceived lightening. L*a*b* measurements were not significantly correlated with the observers' perceptions. L*a*b* assessment is not a clinically useful method to evaluate PDL response in the PWS previously treated. Relying solely on parental assessment may lead to overtreatment without a demonstrable benefit.

Entities:  

Mesh:

Year:  2008        PMID: 18362573     DOI: 10.1097/SAP.0b013e3180959e74

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  2 in total

1.  Quantitative method for evaluation of aesthetic results after laser treatment for birthmarks.

Authors:  Pawel Szychta; Khalil Al-Nakib; Will Anderson; Ken Stewart; Awf Quaba
Journal:  Lasers Med Sci       Date:  2013-02-07       Impact factor: 3.161

2.  Clinical outcome measures and scoring systems used in prospective studies of port wine stains: A systematic review.

Authors:  M Ingmar van Raath; Sandeep Chohan; Albert Wolkerstorfer; Chantal M A M van der Horst; Jacqueline Limpens; Xuan Huang; Baoyue Ding; Gert Storm; René R W J van der Hulst; Michal Heger
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.